58 results
424B3
VCNX
Vaccinex Inc
16 Apr 24
Prospectus supplement
4:55pm
and inflammatory cells at sites of injury, cancer, or infection. We are leveraging our SEMA4D antibody platform and our extensive knowledge of SEMA4D biology
424B5
1uqdsv4qyb4bw3s900
28 Mar 24
Prospectus supplement for primary offering
1:27pm
424B3
1udjldq
19 Jan 24
Prospectus supplement
4:40pm
8-K
EX-99.1
jlse6b97akfz82ua3
26 Oct 23
Vaccinex Reports Positive Effect of Pepinemab Treatment on New Biomarker of Brain Inflammation
9:30am
424B4
qof6xj44 is
2 Oct 23
Prospectus supplement with pricing info
9:16am
424B3
ywzbhnhjflaw n1
11 Jul 23
Prospectus supplement
6:04am
424B5
800 sgivbm
19 May 23
Prospectus supplement for primary offering
5:13pm